These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1291 related articles for article (PubMed ID: 8725882)

  • 1. Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.
    Parker SE; Khatibi S; Margalith M; Anderson D; Yankauckas M; Gromkowski SH; Latimer T; Lew D; Marquet M; Manthorpe M; Hobart P; Hersh E; Stopeck AT; Norman J
    Cancer Gene Ther; 1996; 3(3):175-85. PubMed ID: 8725882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor effect on melanoma by in vivo direct injection of packaging cells transfected recombinant IL-2 gene].
    Zhu Y; Wu Y; Hui Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Apr; 19(2):154-8. PubMed ID: 10453513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology evaluation: interleukin-2 gene therapy for the treatment of renal cell carcinoma.
    Figlin RA; Parker SE; Horton HM
    Curr Opin Mol Ther; 1999 Apr; 1(2):271-8. PubMed ID: 11715951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
    Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
    Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
    Clark PR; Stopeck AT; Ferrari M; Parker SE; Hersh EM
    Cancer Gene Ther; 2000 Jun; 7(6):853-60. PubMed ID: 10880015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.
    Egilmez NK; Cuenca R; Yokota SJ; Sorgi F; Bankert RB
    Gene Ther; 1996 Jul; 3(7):607-14. PubMed ID: 8818648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2 plasmid therapy of murine ovarian carcinoma inhibits the growth of tumor ascites and alters its cytokine profile.
    Horton HM; Dorigo O; Hernandez P; Anderson D; Berek JS; Parker SE
    J Immunol; 1999 Dec; 163(12):6378-85. PubMed ID: 10586027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
    Reimer DL; Kong S; Monck M; Wyles J; Tam P; Wasan EK; Bally MB
    J Pharmacol Exp Ther; 1999 May; 289(2):807-15. PubMed ID: 10215656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor.
    Björkdahl O; Dohlsten M; Sjögren HO
    Cancer Gene Ther; 2000 Oct; 7(10):1365-74. PubMed ID: 11059695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cationic lipid gene transfer of an IL-2 transgene leads to activation of natural killer cells in a SCID mouse human tumor xenograft.
    Clark PR; Stopeck AT; Parker SE; Hersh EM
    Cell Immunol; 2000 Sep; 204(2):96-104. PubMed ID: 11069717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation.
    Lohr F; Lo DY; Zaharoff DA; Hu K; Zhang X; Li Y; Zhao Y; Dewhirst MW; Yuan F; Li CY
    Cancer Res; 2001 Apr; 61(8):3281-4. PubMed ID: 11309280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo antitumor activity of interleukin 21 mediated by natural killer cells.
    Wang G; Tschoi M; Spolski R; Lou Y; Ozaki K; Feng C; Kim G; Leonard WJ; Hwu P
    Cancer Res; 2003 Dec; 63(24):9016-22. PubMed ID: 14695220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of B16(F10) murine melanoma using E. coli cytosine deaminase gene and murine interleukin-4 gene.
    Missol-Kolka E; Sochanik A; Szala S
    Neoplasma; 1998; 45(5):305-11. PubMed ID: 9921920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
    Yi C; Huang Y; Guo ZY; Wang SR
    Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct gene transfer to mouse melanoma by intratumor injection of free DNA.
    Yang JP; Huang L
    Gene Ther; 1996 Jun; 3(6):542-8. PubMed ID: 8789804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer.
    Vieweg J; Boczkowski D; Roberson KM; Edwards DW; Philip M; Philip R; Rudoll T; Smith C; Robertson C; Gilboa E
    Cancer Res; 1995 Jun; 55(11):2366-72. PubMed ID: 7757988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encapsulation of plasmid DNA in stabilized plasmid-lipid particles composed of different cationic lipid concentration for optimal transfection activity.
    Saravolac EG; Ludkovski O; Skirrow R; Ossanlou M; Zhang YP; Giesbrecht C; Thompson J; Thomas S; Stark H; Cullis PR; Scherrer P
    J Drug Target; 2000; 7(6):423-37. PubMed ID: 10758913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of melanoma pulmonary metastasis by intramuscular injection of plasmid DNA encoding tissue inhibitor of metalloproteinases-1.
    Shi Y; Parhar RS; Zou M; Al-Mohanna FA; Paterson MC
    Cancer Gene Ther; 2002 Feb; 9(2):126-32. PubMed ID: 11857029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombined DNA vaccines encoding calreticulin linked to HPV6bE7 enhance immune response and inhibit angiogenic activity in B16 melanoma mouse model expressing HPV 6bE7 antigen.
    Zhao KJ; Cheng H; Zhu KJ; Xu Y; Chen ML; Zhang X; Song T; Ye J; Wang Q; Chen DF
    Arch Dermatol Res; 2006 Jul; 298(2):64-72. PubMed ID: 16710741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.